Dr. Premal Thaker reports IMNN-001 shows early survival benefit in ovarian cancer by activating immune response directly in ...

The New Found Glory singer and guitarist tells PEOPLE that "as painful as it is, I'm able to inspire people going through ...

SAN DIEGO -- Half of heavily pretreated patients with platinum-refractory ovarian cancer (PROC) responded to an ...

A discovery by the Transformation and Metastasis Group of the Spanish National Cancer Research Center (CNIO) opens a path ...

Theriva Biologics Inc (NYSE American:TOVX) shares surged 73.6% Monday following the company’s announcement of new data from its VIRAGE Phase 2b clinical trial evaluating VCN-01 plus chemotherapy in ...

First patient dosing occurred for JANX011 (NCT07291323), a CD19-targeted bispecific inaugurating the ARM platform to enable ...

While the safety was more manageable, questions remain about whether the combination would best antibody-drug conjugate ...

Investigational zoldonrasib was well tolerated and showed encouraging clinical activity in previously treated KRAS ...

Based on positive phase 3 trial results, a New Drug Application will be submitted to the Food and Drug Administration for daraxonrasib.

Choosing between a mastectomy and a lumpectomy? Learn the differences in survival rates, recovery times, and common misconceptions to find the right breast cancer surgery for you.

This work, published in Nature Communications, opens new avenues for identifying tumors with a high risk of developing ...

Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...